CART (55-102) (HUMAN)
|
|
|
- CAS号:
- 214050-22-3
- 英文名:
- CART (55-102) (HUMAN)
- 英文别名:
- CART (55-102);CART (HUMAN, 55-102);CART (55-102) (HUMAN);42-89-Protein CART (human);CART PEPTIDE (AA 55-102), HUMAN;VPIYEKKYGQVPMCDAGEQCAVRKGARIGKLCDCPRGTSCNSFL;COCAINE- AND AMPHETAMINE-REGULATED TRANSCRIPT 55-102;COCAINE- AND AMPHETAMINE-REGULATED TRANSCRIPT (HUMAN, 55-102);COCAINE-AND AMPHETAMINE-REGULATED TRANSCRIPT (55-102) (HUMAN);VPIYEKKYGQVPMCDAGEQCAVRKGARIGKLCDCPRGTSCNSFLLKCL (DISULFIDE BRIDGE: 74-94,68-86 AND 88-101)
- 中文名:
- CART (55-102) (HUMAN)
- 中文别名:
- 内源性饱腹感因子多肽CART(55-102)(HUMAN);H-VAL-PRO-ILE-TYR-GLU-LYS-LYS-TYR-GLY-GLN-VAL-PRO-MET-CYS-ASP-ALA-GLY-GLU-GLN-CYS-ALA-VAL-ARG-LYS-GLY-ALA-ARG-ILE-GLY-LYS-LEU-CYS-ASP-CYS-PRO-ARG-GLY-THR-SER-CYS-ASN-SER-PHE-LEU-LEU-LYS-CYS-LEU-OH
- CBNumber:
- CB2358688
- 分子式:
- C225H365N65O65S7
- 分子量:
- 5245.1571
- MOL File:
- 214050-22-3.mol
|
|
|
CART (55-102) (HUMAN)化学性质
-
储存条件:
-
-15°C
-
|
-
形态:
-
Solid
-
|
-
水溶解性:
-
Soluble to 1 mg/ml in Water
-
|
CART (55-102) (HUMAN)性质、用途与生产工艺
CART(55-102)(human) 是一种具有强烈抑制食欲的内源性饱腹感因子，与瘦素和神经肽 Y 密切相关。
CART (55-102) (HUMAN)
上下游产品信息
上游原料
下游产品
| 更新日期 | 产品编号 | 产品名称 | CAS编号 | 包装 | 价格 |
|---|
| 2024/04/30 | HY-P1304 | CART(55-102)(human) | | 1 mg | 3200元 |
| 2024/04/30 | HY-P1304 | CART(55-102)(human) | | 5 mg | 9500元 |
CART (55-102) (HUMAN)
生产厂家
214050-22-3, CART (55-102) (HUMAN) 相关搜索:
可卡因 三(2,2,6,6-四甲基-3,5-庚二酸)铕 乙二胺氯化铂 对甲基苯磺酰甲基异腈 苯硒酚 乙酰丙酮酸铜 2,2,6,6-四甲基-3,5-庚烷二酸镝 异氰基乙酸乙酯 异腈基乙酸甲酯 乙酰丙酮银 乙酰丙酮钴水合物 双水杨酰胺乙基钴 1,1,3,3-四甲基丁基异氰 乙酰丙酮铬盐 异腈基正丁烷 三乙酰丙酮铁 苄异腈 异氰酸叔丁酯
- peptide
- 目录肽
- 多肽
- 内源性饱腹感因子多肽CART(55-102)(HUMAN)
- H-VAL-PRO-ILE-TYR-GLU-LYS-LYS-TYR-GLY-GLN-VAL-PRO-MET-CYS-ASP-ALA-GLY-GLU-GLN-CYS-ALA-VAL-ARG-LYS-GLY-ALA-ARG-ILE-GLY-LYS-LEU-CYS-ASP-CYS-PRO-ARG-GLY-THR-SER-CYS-ASN-SER-PHE-LEU-LEU-LYS-CYS-LEU-OH
- 214050-22-3
- VPIYEKKYGQVPMCDAGEQCAVRKGARIGKLCDCPRGTSCNSFL
- CART (55-102) (human) trifluoroacetate salt H-Val-Pro-Ile-Tyr-Glu-Lys-Lys-Tyr-Gly-Gln-Val-Pro-Met-Cys-Asp-Ala-Gly-Glu-Gln-Cys-Ala-Val-Arg-Lys-Gly-Ala-Arg-Ile-Gly-Lys-Leu-Cys-Asp-Cys-Pro-Arg-Gly-Thr-Ser-Cys-Asn-Ser-Phe-Leu-Leu-Lys-Cys-Leu-OH trifluoroacetate salt (Disulfide bonds between Cys68 and Cys86/Cys74 and Cys94/Cys88 and Cys101)
- 42-89-Protein CART (human)
- L-Valyl-L-prolyl-L-isoleucyl-L-tyrosyl-L-alpha-glutamyl-L-lysyl-L-lysyl-L-tyrosylglycyl-L-glutaminyl-L-valyl-L-prolyl-L-methionyl-L-cysteinyl-L-alpha-aspartyl-L-alanylglycyl-L-alpha-glutamyl-L-glutaminyl-L-cysteinyl-L-alanyl-L-valyl-L-arginyl-L-lysylglycyl-L-alanyl-L-arginyl-L-isoleucylglycyl-L-lysyl-L-leucyl-L-cysteinyl-L-alpha-aspartyl-L-cysteinyl-L-prolyl-L-arginylglycyl-L-threonyl-L-seryl-L-cysteinyl-L-asparaginyl-L-seryl-L-phenylalanyl-L-leucyl-L-leucyl-L-lysyl-L-cysteinyl-L-leucine cyclic (14-32),(20-40),(34-47)-tris(disulfide)
- VAL-PRO-ILE-TYR-GLU-LYS-LYS-TYR-GLY-GLN-VAL-PRO-MET-CYS-ASP-ALA-GLY-GLU-GLN-CYS-ALA-VAL-ARG-LYS-GLY-ALA-ARG-ILE-GLY-LYS-LEU-CYS-ASP-CYS-PRO-ARG-GLY-THR-SER-CYS-ASN-SER-PHE-LEU-LEU-LYS-CYS-LEU: VPIYEKKYGQVPMCDAGEQCAVRKGARIGKLCDCPRGTSCNSFLLKCL DISULFIDE BRI
- VAL-PRO-ILE-TYR-GLU-LYS-LYS-TYR-GLY-GLN-VAL-PRO-MET-CYS-ASP-ALA-GLY-GLU-GLN-CYS-ALA-VAL-ARG-LYS-GLY-ALA-ARG-ILE-GLY-LYS-LEU-CYS-ASP-CYS-PRO-ARG-GLY-THR-SER-CYS-ASN-SER-PHE-LEU-LEU-LYS-CYS-LEU
- VPIYEKKYGQVPMCDAGEQCAVRKGARIGKLCDCPRGTSCNSFLLKCL (DISULFIDE BRIDGE: 74-94,68-86 AND 88-101)
- COCAINE-AND AMPHETAMINE-REGULATED TRANSCRIPT (55-102) (HUMAN)
- COCAINE- AND AMPHETAMINE-REGULATED TRANSCRIPT 55-102
- COCAINE- AND AMPHETAMINE-REGULATED TRANSCRIPT (HUMAN, 55-102)
- H-VAL-PRO-ILE-TYR-GLU-LYS-LYS-TYR-GLY-GLN-VAL-PRO-MET-CYS-ASP-ALA-GLY-GLU-GLN-CYS-ALA-VAL-ARG-LYS-GLY-ALA-ARG-ILE-GLY-LYS-LEU-CYS-ASP-CYS-PRO-ARG-GLY-THR-SER-CYS-ASN-SER-PHE-LEU-LEU-LYS-CYS-LEU-OH (DISULFIDE BRIDGE: 74-94, 68-86, AND 88-101)
- H-VAL-PRO-ILE-TYR-GLU-LYS-LYS-TYR-GLY-GLN-VAL-PRO-MET-CYS-ASP-ALA-GLY-GLU-GLN-CYS-ALA-VAL-ARG-LYS-GLY-ALA-ARG-ILE-GLY-LYS-LEU-CYS-ASP-CYS-PRO-ARG-GLY-THR-SER-CYS-ASN-SER-PHE-LEU-LEU-LYS-CYS-LEU-OH
- H-VAL-PRO-ILE-TYR-GLU-LYS-LYS-TYR-GLY-GLN-VAL-PRO-MET-CYS-ASP-ALA-GLY-GLU-GLN-CYA-ALA-VAL-ARG-LYS-GLY-ALA-ARG-ILE-GLY-LYS-LEU-CYS-ASP-PRO-ARG-GLY-THR-SER-CYS-ASN-SER-PHELEU-LEU-LYS-CYS-LEU-OH
- CART (55-102) (HUMAN)
- CART (55-102)
- CART (HUMAN, 55-102)
- CART PEPTIDE (AA 55-102), HUMAN